Skip to main content
Contact +1 (919) 234-1277

📢 ProteoGenix Loyalty Program is live — Earn points on every online order. Discover the program

🚀 Special Offer🚀Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

📢 New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
Brand: ProteoGenix

Vonlerolizumab Biosimilar – Anti-TNFRSF4, CD134 mAb – Research Grade

Clonality:
Monoclonal Antibody
Isotype:
IgG1, kappa

$238.00

+ 238 loyalty points
Size
Clear
  • In Stock
  • Wide range of unique reagents
  • Fast worldwide delivery
Vonlerolizumab Biosimilar - Anti-TNFRSF4, CD134 mAb - Research Grade

Vonlerolizumab Biosimilar - Anti-TNFRSF4, CD134 mAb - Research Grade

Product name Vonlerolizumab Biosimilar - Anti-TNFRSF4, CD134 mAb - Research Grade
Source CAS 1638935-72-4
Species Humanized
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Vonlerolizumab,MOXR-0916,MOXR0916,RG-7888,RO7021608,TNFRSF4, CD134,anti-TNFRSF4, CD134
Reference PX-TA1424
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG1-kappa
Clonality Monoclonal Antibody
Product name Vonlerolizumab Biosimilar - Anti-TNFRSF4, CD134 mAb - Research Grade
Source CAS 1638935-72-4
Species Humanized
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Vonlerolizumab,MOXR-0916,MOXR0916,RG-7888,RO7021608,TNFRSF4, CD134,anti-TNFRSF4, CD134
Reference PX-TA1424
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG1-kappa
Clonality Monoclonal Antibody

General information on Anti-TNFRSF4/CD134[Homo sapiens] (Vonlerolizumab) Monoclonal Antibody

Vonlerolizumab is investigated for thr treatment of Locally Advanced or Metastatic Urothelial Carcinoma.

There are no reviews yet.

Be the first to review “Vonlerolizumab Biosimilar – Anti-TNFRSF4, CD134 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products